LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | +33.3% | 15 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $3,000 | +50.0% | 15 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -99.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,821,000 | +14.7% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,588,000 | -98.9% | 15 | -98.9% | 0.00% | -98.7% |
| Q4 2016 | $144,865,000 | +467.8% | 1,415 | +466.0% | 0.15% | +363.6% |
| Q3 2016 | $25,515,000 | -10.1% | 250 | -5.7% | 0.03% | -13.2% |
| Q1 2016 | $28,379,000 | +74.5% | 265 | +76.7% | 0.04% | +90.0% |
| Q4 2015 | $16,263,000 | +26.6% | 150 | 0.0% | 0.02% | +25.0% |
| Q3 2015 | $12,848,000 | – | 150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |